Vitamin D and bone health: Epidemiologic studies

Area of Science:

• Endocrinology
• Bone Biology
• Nutritional Science

Background:

• Vitamin D receptor gene variation linked to osteoporosis.
• Vitamin D system impacts bone homeostasis.
• Controversy surrounds optimal serum 25-hydroxyvitamin D (25(OH)D) levels.

Purpose of the Study:

• Determine optimal serum 25(OH)D levels for bone health.
• Evaluate the skeletal consequences of 25(OH)D insufficiency.
• Assess the effectiveness of vitamin D supplementation for fracture prevention.

Main Methods:

• Biochemical assays
• Observational studies
• Randomized controlled trials (RCTs)

Main Results:

• Serum 25(OH)D levels >= 50 nmol/L normalize parathyroid hormone (PTH), minimize osteomalacia risk, and support bone cell function.
• 25(OH)D insufficiency leads to secondary hyperparathyroidism, increased bone turnover, bone loss, and fracture risk.
• Epidemiological studies show serum 25(OH)D association with bone mineral density; RCTs show mixed results for fracture prevention, particularly in postmenopausal women and older men.

Conclusions:

• Vitamin D is a threshold nutrient for bone health; benefits plateau once PTH is normalized.
• Adequate calcium intake is essential for maximizing vitamin D benefits, especially in those with insufficient 25(OH)D.
• Fracture prevention may benefit from vitamin D and calcium supplementation in specific populations, like the institutionalized elderly with low 25(OH)D.